97
TCGX Asia Life Sciences Fund I, L.P. files a $400M venture capital fund
New fund · Venture capital · Pre-first close · Offering $400M · PALO ALTO, CA · filed 2026-07-29
3(c)(7) — qualified purchasersPre-first closeFirst filing by this entity
TCGX Asia Life Sciences Fund I, a Cayman Islands-based venture capital fund, has closed its $600M offering with 70 institutional investors under Regulation D exemption 3(c)(7). The fund is based in Palo Alto and completed its first sale on July 30, 2026.
| CHEN YU | Director of the Ultimate General Partner |
Signed by Chen Yu, Director of the Ultimate General Partner.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.